Amyloid beta

• The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease (02 Sep 2024)
  
• Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer’s Disease (02 Sep 2024)
  
• Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease (27 Aug 2024)
  
• Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease (25 Aug 2024)
  
• Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders (25 Aug 2024)
  
• CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease (18 Aug 2024)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• Endocannabinoid Metabolism and Traumatic Brain Injury (01 Sep 2022)
  
• CB2 Receptor in Microglia: The Guardian of Self-Control (01 Sep 2022)
  
• The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation (05 Aug 2022)
  
• Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty (31 Jul 2022)
  
• Feline cognitive dysfunction as a model for Alzheimer’s disease in the research of CBD as a potential treatment—a narrative review - Journal of Cannabis Research (26 Jul 2022)